<DOC>
	<DOCNO>NCT01993576</DOCNO>
	<brief_summary>The purpose study determine NIF fluoresent image effctive approch detect margine breast tumoral tissue .</brief_summary>
	<brief_title>ICG Distribution Using NIF Imaging After IV Injection ICG Benign Malignant Breast Cancer Tissue .</brief_title>
	<detailed_description>Primary objective : Definition histological distribution ( intravascular , extra vascular , specific cell ) ICG ( pre-operatively intra-venously inject ) level tumoral healthy tissue breast cancer patient ( potential axillary lymph node find fluorescent ) . Secondary objective : Evaluation ability fluorescence image determine tumor volume , specifically , boundary tumor tissue analyze pathologist . Analysis correlation fluorescence `` margin '' define operatively tumor ( microscopically pathologist ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patients histopathological diagnosis breast cancer mastectomy axillary dissection plan . Informed Consent sign . Diagnosis breast cancer establish lumpectomy `` macrobiopsy '' . Operation neoadjuvant chemotherapy , Age le 18 year . For premenopausal woman , operation plan second phase cycle . Inability give inform consent . History allergy hypersensitivity investigational product , iodine . Clinical biological hyperthyroidism . Known `` toxic '' thyroid nodule know autonomous ( hyperfunctional ) thyroid . A reported pathological coronary artery disease . Creatinine &gt; 1.5 mg / dl . During 2 week surgery , medication know interfere ICG ( ie anticonvulsant , heparin haloperidol ) . Pregnancy breast feeding period .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>